Study on the hydatid cyst membrane: Permeation of model molecules and interactions with drug-loaded nanoparticles

International Journal of Pharmaceutics

Volumn 353, Issue 1-2, 2008, Pages 223-232

  Truong Cong, Tri ^a   Faivre, Vincent ^a   Nguyen, Tien Thanh ^a   Heras, Hernan ^a   Pirot, Fabrice ^a   Walchshofer, Nadia ^a   Sarciron, Marie Elisabeth ^a   Falson, Françoise ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

Albendazole; Diffusion; Echinococcus granulosus; Hydatid cyst; Nanoparticles

Indexed keywords

ALBENDAZOLE; NANOPARTICLE;

ARTICLE; CONCENTRATION RESPONSE; DRUG DIFFUSION; DRUG SOLUBILITY; ECHINOCOCCUS GRANULOSUS; EMULSION; HYDATID CYST; MEMBRANE MODEL; MEMBRANE PERMEABILITY; MOLECULAR MODEL; MOLECULAR WEIGHT; NANOTECHNOLOGY; NONHUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL; SHEEP; SURFACE PROPERTY;

EID: 40149108881     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.11.040     Document Type: Article

References (37)

1. L.I. Alvarez M.L. Mottier S.F. Sanchez C.E. Lanusse Ex vivo diffusion of ABZ and its sulphoxide metabolite into Ascaris suum and Fasciola hepatica Parasitol. Res. 87 2001 929 934
2. C. Bartoloni A. Tricerri L. Guidi The efficacy of chemotherapy with mebendazole in human cystic echinococcosis: long-term follow-up of 52 patients Ann. Trop. Med. Parasitol. 86 1992 249 256
3. N.A. Botsoglou D.J. Fletouris I.E. Psomas A.I. Mantis Retention behaviour of the sulphoxide, sulphone and 2-aminosulphone metabolites of ABZ in ion-pair liquid chromatography Anal. Chim. Acta 354 1997 115 121
4. G. Camenisch G. Folkers H. van de Waterbeemd Review of theoretical passive drug absorption models: historical background, recent developments and limitations Pharm. Acta Helv. 71 1996 309 327
5. K. Daniel-Mwambete S. Torrado C. Cuesta-Bandera F. Ponce-Gordo J.J. Torrado The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs Int. J. Pharm. 272 2004 29 36
6. A.D. Dayan ABZ, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics Acta Trop. 86 2003 141 159
7. N. De Laurentis M.A. Milillo G. Crescenzo S. Bruno A new synthetic method of the main ABZ metabolites Pharm. Pharmacol. Lett. 6 1996 51 53
8. A. Diaz S. Ibarguren M. Breijo A.C. Willis R.B. Sim Host-derived annexin II at the host-parasite interface of the Echinococcus granulosus hydatid cyst Mol. Biochem. Parasitol. 110 2000 171 176
9. P. Ertl B. Rohde P. Seizer Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties J. Med. Chem. 43 2000 3714 3717
10. J.J. Garcia F. Bolas J.J. Torrado Bioavailability and efficacy characteristics of two different oral liquid formulations of ABZ Int. J. Pharm. 250 2003 351 358
11. J.L. Garcia-Llamazares A.I. Alvarez-de-Felipe P.A. Redondo-Cardena J.G. Pieto Fernandez Echinococcus granulosus membrane permeability of secondary hydatid cysts to ABZ sulphoxide Parasitol. Res. 84 1998 417 420
12. T.G. Geary K.L. Blair N. Ho S.M. Sims D.P. Thompson Biological functions of nematode surfaces J.C. Bothroyd R. Komuniecki Molecular Approaches to Parasitology 1995 Wiley-Liss New-York 57 76
13. B. Holcman D.D. Heath The early stages of Echinococcus granulosus development Acta Trop. 64 1997 5 17
14. R.J. Horton Chemotherapy of Echinococcus infection in man with ABZ Trans. R. Soc. Trop. Med. Hyg. 83 1989 97 102
15. R.J. Horton ABZ in treatment of human cystic echinococcosis: 12 years of experience Acta Trop. 64 1997 79 93
16. Klotz, F., Nicolas, X., Debonne, J.-M., Garcia, J.-F., Andreu, J.-M., 2000. Kystes hydatiques du foie. Encycl. Med. Chir., 7-023-A-10, 16p.
17. Y.N. Konan R. Cerny J. Favet M. Berton R. Gurny E. Alléman Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy Eur. J. Pharm. Biopharm. 55 2003 115 124
18. E. Lacey Mode of action of benzimidazoles Parasitol. Today 6 1990 112 115
19. C.E. Lanusse G.L. Virkel S.F. Sanchez L.I. Alvarez A.L. Lifschitz F. Imperiale Ricobendazole kinetics and availability following subcutaneous administration of a novel injectable formulation to calves Res. Vet. Sci. 65 1998 5 10
20. C.A. Lipinski F. Lombardo B.W. Dominy P.J. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliv. Rev. 23 1997 3 25
21. S.M. Moghimi J. Szebeni Stealth liposomes and long circulating nanoparticles: critical isues in pharmacokinetics, opsonization and protein-binding properties Prog. Lipid Res. 42 2003 463 478
22. D. Morris Pre-operative ABZ therapy for hydatid cyst Br. J. Surg. 74 1987 805 806
23. D. Morris J.B. Chinnery C. Ubhi A comparison of the effects of ABZ, its sulphone metabolite, and mebendazole on the viability of protoscoleces of Echinococcus granulosus in an in vitro culture system Trans. R. Soc. Trop. Med. Hyg. 81 1987 804 806
24. M.L. Mottier L.I. Alvarez M.A. Pis C.E. Lanusse Transtegumental diffusion of benzimidazole anthelmintics into Moniezia benedeni : correlation with their octanol–water partition coefficients Exp. Parasitol. 103 2003 1 7
25. M.A. Navia P.R. Chaturvedi Design principles for orally bioavailable drugs Drug Discov. Today 1 1996 179 189
26. D. Quintanar-Guerrero H. Fessi E. Allémann E. Doelker Influence of stabilizing agents and preparative variables on the formation of poly( d , l -lactic acid) nanoparticles by an emulsification-diffusion technique Int. J. Pharm. 143 1996 133 141
27. P.A. Redondo A.I. Alvarez J.L. Garcia C. Villaverde J.G. Prieto Influence of surfactants on oral bioavailability of ABZ based on the formation of the sulphoxide metabolites in rats Biopharm. Drug Dispos. 19 1998 65 70
28. 14C] mebendazole Int. J. Parasitol. 7 1977 189 194
29. J. Rodrigues C. Bories I. Emery H. Fessi J. Devissaguet M. Liance Development of an injectable formulation of ABZ and in vivo evaluation of its efficacy against Echinococcus multilocularis metacestode Int. J. Parasitol. 25 1995 1437 1441
30. A.G. Saimot Medical treatment of liver hydatidosis World J. Surg. 25 2001 15 20
31. O.F. Senyuz E. Yesildag S. Celayir ABZ therapy in the treatment of hydatid liver disease Surg. Today 31 2001 487 491
32. R.A. Smego P. Sebanego Treatment options for hepatic cystic echinococcosis Int. J. Infect. Dis. 9 2005 69 76
33. K.S. Soppimath T.M. Aminabhavi A.R. Kulkarn W.E. Rudzinski Biodegradable polymeric nanoparticles as drug delivery devices J. Control. Release 70 2001 1 20
34. S. Torrado S. Torrado R. Cadorniga J.J. Torrado Formulation parameters of ABZ solution Int. J. Pharm. 140 1996 45 50
35. D.F. Veber S.R. Johnson H.-Y. Cheng B.R. Smith K.W. Ward K.D. Koppie Molecular properties that influence the oral bioavailability of drug candidates J. Med. Chem. 45 2002 2615 2623
36. Z. Wu M. Razzak I.G. Tucker N.J. Medlicott Physicochemical characterization of ricobendazole. I. Solubility, lipophilicity, and ionization characteristics J. Pharm. Sci. 94 2005 983 993
37. S.H. Xiao J.Q. You H.F. Guo J.J. Feng H.L. Sun P.Y. Jiao M.Y. Yao J.J. Chai Effect of mebendazole on glucose uptake of Echinococcus granulosus cyst Acta Pharmacol. Sin. 13 1992 473 477